Evaluation of the use of piperacillin/tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions?
Fahmi Yousef Khan1, Abdelhaleem Elhiday1, Imran Fahmi Khudair2, Hind Yousef3, Aisha Hussein Omran4, Samer Hytham Alsamman1, Maha Elhamid21Department of Medicine, 2Clinical Service, Pharmacy Department, 3Endocrine Division, Department of Medicine, 4Chest Team, Department of Medicine, Hamad General Ho...
Main Authors: | Khan FY, Elhiday A, Khudair IF, Yousef H, Omran AH, Alsamman SH, Elhamid M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-01-01
|
Series: | Infection and Drug Resistance |
Online Access: | http://www.dovepress.com/evaluation-of-the-use-of-piperacillintazobactam-tazocinreg-at-hamad-ge-a9059 |
Similar Items
-
Piperacillin/Tazobactam (ZOSYN)
by: Stephanie M. Culver, et al.
Published: (1996-01-01) -
Frequency of Acute Kidney Injury in Patient Receiving Piperacillin - Tazobactam: A Hospital-based Study from Qatar
by: Fahmi Yousef Khan, et al.
Published: (2021-07-01) -
Piperacillin–tazobactam as alternative to carbapenems for ICU patients
by: Benoit Pilmis, et al.
Published: (2017-11-01) -
Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
by: Aikaterini Kyriakou, et al.
Published: (2019-01-01) -
Piperacillin/Tazobactam-Induced Neutropenia: A Case Report
by: Hayati DEMİRASLAN, et al.
Published: (2012-03-01)